News tagged with monoclonal antibodies
Related topics: breast cancer , cancer , cancer cells , antibodies , immune system
New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
A newly developed antibody targeting a signalling pathway that is frequently active in solid tumours has shown encouraging signs of efficacy in its first trial in humans, researchers will report at the 24th EORTC-NCI-AACR ...
Cancer
Nov 06, 2012 |
5 / 5 (2) |
0
New drug may help those who can't take statins
(HealthDay)—An experimental drug may help patients who can't tolerate statins lower their cholesterol, a new Australian study suggests.
Cardiology
Nov 05, 2012 |
4 / 5 (3) |
0
|
Scientists identify new target for lung cancer treatment
A team of UC Davis investigators has discovered a protein on the surface of lung cancer cells that could prove to be an important new target for anti-cancer therapy. A series of experiments in mice with lung cancer showed ...
Cancer
Nov 01, 2012 |
4 / 5 (1) |
0
|
Lexatumumab tolerated for pediatric solid tumors
(HealthDay)—Lexatumumab, an agonistic, full human monoclonal antibody against tumor necrosis factor-related apoptosis-inducing ligand receptor 2, is well tolerated and may lessen certain clinical symptoms ...
Cancer
Oct 16, 2012 |
5 / 5 (1) |
0
Ebola antibody treatment, produced in plants, protects monkeys from lethal disease
A new Ebola virus study resulting from a widespread scientific collaboration has shown promising preliminary results, preventing disease in infected nonhuman primates using monoclonal antibodies.
Medical research
Oct 15, 2012 |
4.8 / 5 (4) |
1
|
Women respond better to the treatment of lymph gland cancer with antibodies than men
(Medical Xpress)—Women respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of a multi-centre, Austria-wide ...
Cancer
Oct 10, 2012 |
5 / 5 (1) |
0
Monoclonal antibody effective therapy for diabetic retinopathy
(HealthDay)—An antibody can reduce retinal vascular leakage and inflammation in rat models of diabetic retinopathy, according to a study published online Oct. 1 in Diabetes.
Diabetes
Oct 07, 2012 |
not rated yet |
0
|
Study suggests treatments for 'wet' AMD keep elderly drivers behind the wheel
The advanced neovascular, or "wet," form of age-related macular degeneration (AMD), left untreated, is the most common cause of vision loss among the elderly and a leading reason for their loss of driving privileges. But ...
Ophthalmology
Oct 02, 2012 |
not rated yet |
0
Adding bavituximab to second-line chemotherapy doubles response rate
Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small cell lung cancer (NS-NSCLC) ...
Cancer
Sep 06, 2012 |
5 / 5 (2) |
0
Antibody prevents hepatitis C in animal model
A monoclonal antibody developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus ...
Diseases, Conditions, Syndromes
Aug 30, 2012 |
5 / 5 (1) |
0
|
Cetuximab, paclitaxel combo active in urothelial cancer
(HealthDay)—The monoclonal antibody against epidermal growth factor receptor (EGFR), cetuximab, augments the antitumor activity of paclitaxel in patients with previously treated urothelial cancer, according ...
Cancer
Aug 29, 2012 |
not rated yet |
0
Belimumab for lupus erythematosus: Added benefit not proven
Belimumab (trade name Benlysta) has been approved since July 2011 as an add-on therapy for adult patients with the autoimmune disease systemic lupus erythematosus (SLE). This monoclonal antibody is only considered as treatment ...
Cancer
Aug 29, 2012 |
not rated yet |
0
Dual action polyclonal antibody may offer more effective, safer protection against osteoporosis
A new study suggests that a polyclonal antibody that blocks follicle-stimulating hormone (FSH) in mice without ovaries might offer a more effective way to prevent or arrest osteoporosis than currently available treatments.
Medical research
Aug 20, 2012 |
5 / 5 (1) |
0
|
Mepolizumab almost halves exacerbations in patients with severe asthma
The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduct ...
Immunology
Aug 16, 2012 |
not rated yet |
0
Clinical trial for rabies monoclonal antibody
A pivotal clinical trial for an anti-rabies human monoclonal antibody (RMAb) being developed through a collaborative partnership between MassBiologics of the University of Massachusetts Medical School and the Serum Institute ...
Diseases, Conditions, Syndromes
Aug 07, 2012 |
not rated yet |
0
